Blog

Enhanced Detection with Probe-Based Confocal Laser Endomicroscopy

Probe-based confocal laser endomicroscopy (pCLE) significantly improves real-time diagnosis during endoscopy for various gastrointestinal conditions.

  • In Barrett’s esophagus, pCLE nearly doubles neoplasia detection sensitivity compared to conventional methods.
  • For gastric intestinal metaplasia, sensitivity reached 97% and specificity 94%.
  • Colorectal lesion evaluation shows sensitivity of 81-91% and specificity of 75-91%, reducing unnecessary resections.

PCLE can lead to fewer biopsies and earlier interventions, promoting better patient outcomes. Further standardization and AI integration will enhance its clinical adoption.

Review by Ayyad M, Gala D (…) Hajifathalian K et 4 al. in Surg Endosc

© 2025. The Author(s).

read the whole article in Surg Endosc

open it in PubMed

Laparoscopic Splenectomy Enhances Recompensation in Cirrhosis

Laparoscopic splenectomy significantly improves liver function in decompensated cirrhosis patients.

  • 73% of patients treated with splenectomy achieved recompensation versus 33% with endoscopic therapy.
  • Recompensation contributed to a 43% reduction in mortality over 3 years, dropping to 16% by 8 years.

Younger patients have better outcomes with this approach.

  • Overall, 54% of patients in the study met the Baveno VII criteria for recompensation.

Journal Article by Zhou LX, He CH (…) Jiang GQ et 10 al. in J Gastroenterol

© 2025. The Author(s), under exclusive licence to Japanese Society of Gastroenterology.

read the whole article in J Gastroenterol

open it in PubMed

Intraoperative Blood Loss Affects Pancreatic Fistula Rates

Intraoperative blood loss is a key risk factor for postoperative pancreatic fistula (POPF) in pancreatic surgery, impacting patient recovery.

  • Among 13,108 patients, the overall POPF rate was 20%.
  • In patients with POPF, intraoperative blood loss was 112.46 ml higher than those without, highlighting its significance as an independent risk factor.

Minimizing blood loss during surgery could enhance outcomes and reduce complications for pancreatic surgery patients.

Systematic Review by Perri G, Heo D (…) Marchegiani G et 6 al. in Langenbecks Arch Surg

© 2025. The Author(s).

read the whole article in Langenbecks Arch Surg

open it in PubMed

Hemoglobin-to-albumin ratio predicts complications after gastrectomy

Higher hemoglobin-to-albumin ratios are linked to fewer complications post-radical gastrectomy in gastric cancer patients.

  • A 1-unit increase in the hemoglobin-to-albumin ratio reduces the risk of moderate to severe complications (Clavien-Dindo ≥II) by 62%.
  • This study analyzed data from 352 patients, establishing a clear correlation between nutritional status and surgical outcomes.

Monitor hemoglobin-to-albumin ratios to optimize patient selection and enhance recovery in gastric surgery.

Journal Article by Luo W, Li R, Pan C and Luo C in Front Med (Lausanne)

Copyright © 2025 Luo, Li, Pan and Luo.

read the whole article in Front Med (Lausanne)

open it in PubMed

Strategies to Reduce Delayed Gastric Emptying Post-Pancreatic Surgery

Delayed gastric emptying (DGE) is a major complication after pancreatic surgery, impacting recovery and hospital stays.

  • The overall DGE grade B/C rate was 11.9%, with 12.7% after pancreatoduodenectomy and 4.2% after left pancreatectomy.
  • No effective treatments for DGE were found, but 12 strategies showed promise in reducing rates, notably minimally invasive left pancreatectomy.

Minimally invasive techniques may offer the best prevention against DGE, underscoring the need for further research in this area.

Journal Article by Montorsi RM, Strijbos BTM (…) Besselink MG et 7 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Laparoscopic Resection Rectopexy Outperforms Delorme’s for Rectal Prolapse

Laparoscopic resection rectopexy significantly reduces recurrence rates in full-thickness rectal prolapse compared to Delorme’s procedure.

  • Recurrence rates within 24 months: 8.2% for laparoscopic resection vs. 42.8% for Delorme’s.
  • Laparoscopic surgery had a median time to recurrence of 17.8 months, compared to 8.2 months for Delorme’s.

Choose laparoscopic resection for better long-term outcomes and improved quality of life for your patients.

  • Overall morbidity was low, with reoperation rates at 0% for laparoscopic resection and 33.3% for Delorme’s.

Journal Article by Herrle F, Sandra-Petrescu F (…) Kienle P et 30 al. in Ann Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Ann Surg

open it in PubMed

Neoadjuvant Therapy Improves Outcomes in Intrahepatic Cholangiocarcinoma

Neoadjuvant chemotherapy followed by surgery significantly improves survival and reduces recurrence in patients with potentially resectable intrahepatic cholangiocarcinoma.

  • Median overall survival was 52.9 months for neoadjuvant therapy versus 37.0 months for upfront surgery.
  • Recurrence risk was lower at 57.7% compared to 65.7%, and the time to relapse extended to 16.5 months from 10.7 months.

This evidence supports considering neoadjuvant chemotherapy as a standard approach for high-risk patients.

  • Five-year survival rates reached 45.7% with neoadjuvant therapy, compared to 32.5% with upfront surgery.

Journal Article by Elemosho A, Chatzipanagiotou OP, Angez M and Pawlik TM in J Gastrointest Surg

Copyright © 2025 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.

read the whole article in J Gastrointest Surg

open it in PubMed

Gallstone Disease and Lifestyle Factors: A New Approach

Higher lifestyle health scores may reduce gallstone disease risk.

  • A standard deviation increase in Life’s Essential 8 (le8) decreases gallstone odds by 29%.
  • Life’s Crucial 9 (lc9), which includes mental health, reduces odds by 31% and shows better predictive power than le8.

Consider integrating lifestyle assessments into patient evaluations to lower gallstone disease risk.

  • lc9 offers a stronger framework for lifestyle counseling and prevention strategies during surgical decision-making.

Journal Article by Wang J, Le Q (…) Wang H et 2 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Gastric Cancer Treatment Shift: Prioritizing Patient Outcomes

Gastric cancer with peritoneal metastases is rising, especially in younger patients, highlighting the urgent need for better outcomes.

  • Novel therapies like normothermic intraperitoneal and systemic chemotherapy have shown overall survival benefits.
  • Patient-reported outcomes remain underreported in major trials, with critical insights missed from studies like Dragon-01.

Incorporating tailored patient-reported measures into clinical trials is essential for improving survivors’ quality of life alongside survival rates.

  • Enhanced focus on patient experience will guide effective treatment strategies moving forward.

Review by Burke E in J Gastrointest Cancer

© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in J Gastrointest Cancer

open it in PubMed

Effective Weight Loss Device for Type 2 Diabetes and Obesity

An endoscopically placed bypass liner significantly improves glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.

  • HbA1c reduction at 12 months was -1.10% for the bypass group versus -0.28% for sham (p=0.0004).
  • Patients in the bypass group experienced a 7.7% total weight loss compared to 2.1% in the sham group (p<0.0001).

Consider this device for patients struggling with both diabetes management and obesity; it shows potential for better surgical outcomes and patient quality of life.

  • 28.3% of the bypass group achieved HbA1c ≤ 7% compared to 9.4% in the sham group (p<0.0003).

Journal Article by Thompson CC, Jirapinyo P (…) Schauer P et 12 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed